Showing 1,841 - 1,860 results of 122,881 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 1.73s Refine Results
  1. 1841
  2. 1842
  3. 1843
  4. 1844
  5. 1845

    Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography by O. Stivalet (6890189)

    Published 2019
    “…The receiver-operating-characteristic curve was used to define a cut-off point corresponding to the best area under the curve (AUC; [CI95%]) to detect arterial stenosis ≥50% as determined by the CTA.…”
  6. 1846
  7. 1847

    Plasma miR-92a expression level and ROC curve in patients with non-Hodgkin's lymphoma by quantitative real-time PCR. by Kazuma Ohyashiki (229098)

    Published 2011
    “…<p>(A) Plasma miR-17-92a expression levels in normal subjects (open bars: Normal: n = 5) and diffuse large B-cell lymphoma (solid bars: DLBCL: n = 13), indicating that all of these miR-17-92a polycistronic miRs were remarkably decreased in plasma obtained from DLBCL patients. …”
  8. 1848
  9. 1849
  10. 1850

    Vitamin D3, but not the Cisplatin, could moderately reduce STZ-induced hyperglycemia in mice (a) Schematic representation of experimental protocol followed in the study: After accl... by Vidya G. Bettada (22208808)

    Published 2025
    “…<p>The control non-diabetic group was administered with the vehicle used for dissolving the STZ, i.e., 100mM sodium citrate buffer, pH 4.5. …”
  11. 1851

    Strains used in this study. by Xin Zhou (54275)

    Published 2024
    “…Dysfunction of <i>ERG251</i>, together with FLC exposure, resulted in decreased accumulation of the toxic sterol (14-ɑ-methylergosta-8,24(28)-dien-3β,6α-diol) and increased accumulation of non-toxic alternative sterols. …”
  12. 1852

    Primers used in this study. by Xin Zhou (54275)

    Published 2024
    “…Dysfunction of <i>ERG251</i>, together with FLC exposure, resulted in decreased accumulation of the toxic sterol (14-ɑ-methylergosta-8,24(28)-dien-3β,6α-diol) and increased accumulation of non-toxic alternative sterols. …”
  13. 1853

    Results of comparison between Model5 and Model9. by Taiga Mori (21410076)

    Published 2025
    “…We then define the magnitude as the difference between the lowest and highest points of the head within a cycle. In the analysis, we demonstrate that this magnitude varies depending on length and position, thereby providing evidence that nods exhibit a structured pattern. …”
  14. 1854

    Results of comparison between Model5 and Model10. by Taiga Mori (21410076)

    Published 2025
    “…We then define the magnitude as the difference between the lowest and highest points of the head within a cycle. In the analysis, we demonstrate that this magnitude varies depending on length and position, thereby providing evidence that nods exhibit a structured pattern. …”
  15. 1855

    <i>ERG251</i> SNPs from all FLC-evolved strains. by Xin Zhou (54275)

    Published 2024
    “…Dysfunction of <i>ERG251</i>, together with FLC exposure, resulted in decreased accumulation of the toxic sterol (14-ɑ-methylergosta-8,24(28)-dien-3β,6α-diol) and increased accumulation of non-toxic alternative sterols. …”
  16. 1856
  17. 1857
  18. 1858
  19. 1859
  20. 1860